Scientists say identification of two epigenetically different states in mouse model opens door to "entirely new world of ...

Limited to estrogen receptor-positive breast cancer (ER+) the compound addresses many common concerns with existing treatment ...

More testing is needed, but if the same results are seen in humans, it could transform treatment of the disease.

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment ...

Exciting research unveils a single-dose treatment that could potentially change breast cancer therapy by eliminating small tumors and reducing large ones in mice without notable side effects. A ...

Glycolysis is a central metabolic pathway by which cells obtain energy from sugar. Cancer cells in particular have long been ...

“It is very rare for a compound to shrink tumors in mouse models of breast cancer, let alone completely eradicate those tumors with a single dose, so we are eager for ErSO-TFPy to advance for ...

Learn how early developmental patterns can influence your lifetime cancer risk and the type of cancer that may develop.